Allan Jonathan
Stoke Therapeutics, Inc. · GENERAL COUNSEL & CORP SEC
Allan Jonathan is listed in filings as GENERAL COUNSEL & CORP SEC at Stoke Therapeutics, Inc.. This profile follows SEC Form 4 activity through Mar 24, 2026, including sale activity. Recent filings connect the profile to Stoke Therapeutics, Inc. (STOK). The current snapshot covers public activity from Dec 3, 2024 to Mar 24, 2026. Reported amounts are shown as $123.9K to $165.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $21k601 shares | SellMar 20, 2026 | $34.41 | $29.11 | |
| $292k8.7k shares | SellMar 20, 2026 | $33.64 | $29.11 |